BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25211284)

  • 21. A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection.
    Li XL; Wei HX; Zhang H; Peng HJ; Lindsay DS
    PLoS One; 2014; 9(5):e97775. PubMed ID: 24830795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Toxoplasma infections in early pregnancy: consequences and management].
    Wallon M; Gaucherand P; Al Kurdi M; Peyron F
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital toxoplasmosis: What is the evidence for chemoprophylaxis to prevent fetal infection?
    Mandelbrot L
    Prenat Diagn; 2020 Dec; 40(13):1693-1702. PubMed ID: 32453454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
    Foulon W; Villena I; Stray-Pedersen B; Decoster A; Lappalainen M; Pinon JM; Jenum PA; Hedman K; Naessens A
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):410-5. PubMed ID: 9988811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital toxoplasmosis: therapeutic strategies.
    Foulon W
    Arch Pediatr; 2003 Feb; 10 Suppl 1():10-1. PubMed ID: 12802954
    [No Abstract]   [Full Text] [Related]  

  • 26. Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection.
    Robert-Gangneux F; Yera H; D'Herve D; Guiguen C
    Pediatr Infect Dis J; 2009 Jul; 28(7):660-1. PubMed ID: 19561432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
    Pelloux H; Fricker-Hidalgo H; Pons JC; Bost-Bru C; Brenier-Pinchart MP; Jouk PS; Ambroise-Thomas P
    Arch Pediatr; 2002 Feb; 9(2):206-12. PubMed ID: 11915504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
    Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Congenital toxoplasmosis retinochoroiditis after primary infection of the mother in pregnancy].
    Kuchar A; Hayde M; Steinkogler FJ
    Ophthalmologe; 1996 Apr; 93(2):190-3. PubMed ID: 8652987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The placenta: a main role in congenital toxoplasmosis?
    Robert-Gangneux F; Murat JB; Fricker-Hidalgo H; Brenier-Pinchart MP; Gangneux JP; Pelloux H
    Trends Parasitol; 2011 Dec; 27(12):530-6. PubMed ID: 22079164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
    Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
    Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of congenital toxoplasmosis].
    Russo M; Galanti B
    Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of congenital toxoplasmosis in France: current data].
    Garcia-Méric P; Franck J; Dumon H; Piarroux R
    Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid.
    Gratzl R; Hayde M; Kohlhauser C; Hermon M; Burda G; Strobl W; Pollak A
    Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):853-8. PubMed ID: 10052549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of toxoplasmosis.
    Georgiev VS
    Drugs; 1994 Aug; 48(2):179-88. PubMed ID: 7527323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxoplasmosis and pregnancy.
    Chaudhry SA; Gad N; Koren G
    Can Fam Physician; 2014 Apr; 60(4):334-6. PubMed ID: 24733322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Toxoplasmosis in pregnancy: Practical Management].
    Mandelbrot L; Kieffer F; Wallon M; Winer N; Massardier J; Picone O; Fuchs F; Benoist G; Garcia-Meric P; L'Ollivier C; Paris L; Piarroux R; Villena I; Peyron F
    Gynecol Obstet Fertil Senol; 2021 Oct; 49(10):782-791. PubMed ID: 33677120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection.
    Couvreur J; Desmonts G; Thulliez P
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():193-200. PubMed ID: 3182443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.
    Gras L; Gilbert RE; Ades AE; Dunn DT
    Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Congenital toxoplasmosis and seroconversion at the end of pregnancy: clinical observations].
    Luyasu V; Bauraind O; Bernard P; Bietlot Y; Brasseur C; Englebert J; Fiasse L; Givron O; Longueville E; Melard JL; Michel M; Wacquez M
    Acta Clin Belg; 1997; 52(6):381-7. PubMed ID: 9489134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.